Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Adipocytokine signaling pathway 💬 16 genes, 38 drugs (DrugBank) and 104 diseases |
NR1C1 [1] NR1C1 💬Adipocytokine signaling pathway
|
Bezafibrate Bezafibrate 💬Adipocytokine signaling pathway
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬1. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||
2 | Alcoholic liver disease 💬 42 genes, 54 drugs (DrugBank) and 91 diseases |
NR1C1 [1] NR1C1 💬Alcoholic liver disease
|
Bezafibrate Bezafibrate 💬Alcoholic liver disease
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬2. Alcoholic liver disease
|
||||||||||||||||||||||||||
3 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
NR1C1 [1] NR1C1 💬cAMP signaling pathway
|
Bezafibrate Bezafibrate 💬cAMP signaling pathway
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬3. cAMP signaling pathway
|
||||||||||||||||||||||||||
4 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
NR1C1 [1] NR1C1 💬Chemical carcinogenesis - receptor activation
|
Bezafibrate Bezafibrate 💬Chemical carcinogenesis - receptor activation
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬4. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||
5 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
NR1C1 [1] NR1C1 💬Diabetic cardiomyopathy
|
Bezafibrate Bezafibrate 💬Diabetic cardiomyopathy
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬5. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||
6 | Glucagon signaling pathway 💬 14 genes, 23 drugs (DrugBank) and 82 diseases |
NR1C1 [1] NR1C1 💬Glucagon signaling pathway
|
Bezafibrate Bezafibrate 💬Glucagon signaling pathway
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬6. Glucagon signaling pathway
|
||||||||||||||||||||||||||
7 | Hepatitis C 💬 36 genes, 70 drugs (DrugBank) and 87 diseases |
NR1C1 [1] NR1C1 💬Hepatitis C
|
Bezafibrate Bezafibrate 💬Hepatitis C
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬7. Hepatitis C
|
||||||||||||||||||||||||||
8 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 100 diseases |
NR1C1 [1] NR1C1 💬Insulin resistance
|
Bezafibrate Bezafibrate 💬Insulin resistance
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬8. Insulin resistance
|
||||||||||||||||||||||||||
9 | Non-alcoholic fatty liver disease 💬 23 genes, 52 drugs (DrugBank) and 95 diseases |
NR1C1 [1] NR1C1 💬Non-alcoholic fatty liver disease
|
Bezafibrate Bezafibrate 💬Non-alcoholic fatty liver disease
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬9. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||
10 | PPAR signaling pathway 💬 12 genes, 18 drugs (DrugBank) and 35 diseases |
NR1C1 [1] NR1C1 💬PPAR signaling pathway
|
Bezafibrate Bezafibrate 💬PPAR signaling pathway
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬10. PPAR signaling pathway
|
Adipocytokine signaling pathway
16 genes, 38 drugs (DrugBank) and 104 diseases
Alcoholic liver disease
42 genes, 54 drugs (DrugBank) and 91 diseases
cAMP signaling pathway
66 genes, 189 drugs (DrugBank) and 130 diseases
Chemical carcinogenesis - receptor activation
39 genes, 135 drugs (DrugBank) and 134 diseases
Diabetic cardiomyopathy
28 genes, 48 drugs (DrugBank) and 79 diseases
Glucagon signaling pathway
14 genes, 23 drugs (DrugBank) and 82 diseases
Hepatitis C
36 genes, 70 drugs (DrugBank) and 87 diseases
Insulin resistance
19 genes, 38 drugs (DrugBank) and 100 diseases
Non-alcoholic fatty liver disease
23 genes, 52 drugs (DrugBank) and 95 diseases
PPAR signaling pathway
12 genes, 18 drugs (DrugBank) and 35 diseases